In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Contrafect Corp (NASDAQ:CFRX) reported that Federated Investors Inc /pa/ has picked up 4,000,000 of common stock as of 2017-02-14.
The acquisition brings the aggregate amount owned by Federated Investors Inc /pa/ to a total of 4,000,000 representing a 9.18% stake in the company.
For those not familiar with the company, Contrafect Corp (NASDAQ:CFRX) is a biotechnology company focused on developing treatments for drug resistant, life-threatening infectious diseases. Their lysin and monoclonal antibody products represent new approaches to treating infections.
A glance at Contrafect Corp. (NASDAQ:CFRX)’s key stats reveals a current market capitalization of 70.68 million based on 41.58 million shares outstanding and a price at last close of $1.71 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-07-27, Keizer picked up 20,000 at a purchase price of $2.48. This brings their total holding to 20,000 as of the date of the filing.
On the sell side, the most recent transaction saw Couto unload 2,872 shares at a sale price of $3.81. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Contrafect Corp. (NASDAQ:CFRX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.